Cell Signaling Technology

NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (PE Conjugate)

#15003 · western blot · $180,465

65
Evidence Score · Well-Established
Used by 348 independent labs across 387 papers. How we score this →
100
Citing papers
3.3k
Combined citations
Supplier page Find this product

Research areas

Melanoma and MAPK Pathways15Autophagy in Disease and Therapy6Cytokine Signaling Pathways and Interactions6PI3K/AKT/mTOR signaling in cancer5Cancer Genomics and Diagnostics4Epigenetics and DNA Methylation4Cancer Mechanisms and Therapy4Cancer Cells and Metastasis4

Papers citing this product

1
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
International Journal of Oncology·2015·363 cit.·DOI
2
Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells
British Journal of Cancer·2015·173 cit.·DOI
3
RNA Interference Screen Identifies Abl Kinase and PDGFR Signaling in Chlamydia trachomatis Entry
PLoS Pathogens·2008·148 cit.·DOI
4
A unique pathway for sustained neurotrophin signaling through an ankyrin‐rich membrane‐spanning protein
The EMBO Journal·2004·143 cit.·DOI
5
Fluorescent Indicators for Akt/Protein Kinase B and Dynamics of Akt Activity Visualized in Living Cells
Journal of Biological Chemistry·2003·139 cit.·DOI
6
Deubiquitination of CXCR4 by USP14 Is Critical for Both CXCL12-induced CXCR4 Degradation and Chemotaxis but Not ERK Activation
Journal of Biological Chemistry·2008·102 cit.·DOI
7
Fibroblast Growth Factor Inducible 14 (Fn14) Is Required for the Expression of Myogenic Regulatory Factors and Differentiation of Myoblasts into Myotubes
Journal of Biological Chemistry·2007·95 cit.·DOI
8
A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells
Clinical Cancer Research·2010·94 cit.·DOI
9
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Journal of Experimental & Clinical Cancer Research·2019·84 cit.·DOI
10
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
Scientific Reports·2019·81 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology65$152,351100
NF-kappaB2 p100/p52 AntibodyRabbitCell Signaling Technology65$135,314100
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)RabbitCell Signaling Technology65$45824
NF-kappaB2 p100/p52 (D7A9K) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology65$157,34818
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ UV375 Conjugate)RabbitCell Signaling Technology65$45814
NF-kappaB2 p100/p52 (D9S3M) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology65$161,3519
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 750 Conjugate)RabbitCell Signaling Technology65$4585
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Red 780 Conjugate)RabbitCell Signaling Technology65$4584
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology65$8654
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 555 Conjugate)RabbitCell Signaling Technology65$4583
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)RabbitCell Signaling Technology65$4582
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 532 Conjugate)RabbitCell Signaling Technology65$4581
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 700 Conjugate)RabbitCell Signaling Technology65$4581
NF-kappaB2 p100/p52 (18D10) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)RabbitCell Signaling Technology65$4581

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.